Events

Events Search and Views Navigation

Event Views Navigation

Today

ASM Microbe 2018 – Presentation by Karen Gallant

Georgia World Congress Center 285 Andrew Young International Blvd NW, Atlanta, GA, United States

Karen Gallant to present at the American Society of Microbiology - connecting scientists with their science

Understanding the Development Challenges Associated with Emerging Non-Traditional Antibiotics

JW Marriott Washington DC 1331 Pennsylvania Avenue NW, Washington, DC, United States

Convened by the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University and supported by a cooperative agreement with FDA, this public event will focus on the range of non-traditional pharmaceutical approaches being developed to combat bacterial infections. Kevin Outterson and John Rex to present.

GARDP Live Discussion Webinar: PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?

Webinar

In this webinar, William Hope will talk about the role of pharmacokinetics and pharmacodynamics for antimicrobial drug development. He will discuss the EMA guideline on the use of PK/PD and basic studies to inform dose finding strategies. He will also advise on realistic benchmarking, endpoints, and interpretation of study results.

Payment Reform Pathways for Antimicrobial Drugs: Duke-Margolis Center for Health Policy Roundtable Meeting

Washington, DC

Facilitating Payment Reform Pathways for Antimicrobial Drugs through FDA and CMS Collaboration As you know, the rise in antimicrobial resistant infections is a major public health threat. Few treatment options are available and the pipeline of drug candidates is extremely limited. To help address this issue, Duke-Margolis has been focused on policy initiatives that could […]

FDA Development of Non-Traditional Therapies for Bacterial Infections Workshop

FDA White Oak Campus - Building 31 10903 New Hampshire Ave, Silver Spring, MD, United States

The Food and Drug Administration is holding a public workshop entitled “Development of Non-Traditional Therapies for Bacterial Infections." The purpose of the public workshop is to discuss the general development considerations of non-traditional therapies, including pre-clinical development, early clinical studies, and phase 3 clinical trial designs to evaluate safety and efficacy. Presentations by Kevin Outterson, […]

Next Generation Dx Summit: Investment Plenary Panel – Changing Approaches to Sustainable Funding in Diagnostics

Grand Hyatt Washington 1000 H St NW, Washington, DC, United States

Today, many innovators in the diagnostics industry struggle for funding, and yet news of large scale acquisitions or large (over $30M) funding rounds pops up regularly. How can innovators better understand the changing dynamics of the funding environment to succeed? How can investors know if they are getting exposed to the potentially best investments? Whether […]